Company / Free Cash Flow
Imunon, Inc. Free Cash Flow History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$23.4M
FY2023
5-year range
-$23.4M / -$7.2M
FY2019-FY2023
Trend
-41.3%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has fluctuated over the past 7 years, ranging from -$23M in FY2023 to -$7M in FY2019.
Based on SEC 10-K filings.
-$23M in FY2023.
Declined from -$16M to -$23M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, free cash flow decreased 41.3% year-over-year.
- Peak free cash flow was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | -$23.4M | -41.3% |
| FY2022 | -$16.5M | -5.7% |
| FY2021 | -$15.6M | +24.1% |
| FY2020 | -$20.6M | -187.0% |
| FY2019 | -$7.2M | +57.0% |
| FY2018 | -$16.7M | -74.1% |
| FY2015 | -$9.6M | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026